https://peptide.zone/story/hhs-peptide-compounding-policy-experts-splitPeptide Zoneen2026-11-01T04:51:00.000ZHHS peptide compounding policy splits pharmacists and pharmacologists https://peptide.zone/story/glp-1-cold-medicine-nsaids-pill-timingPeptide Zoneen2026-10-31T04:55:00.000ZGLP 1 cold medicine advice flags NSAIDs and pill timing in flu season https://peptide.zone/story/retatrutide-liver-failure-unapproved-vialPeptide Zoneen2026-10-31T04:26:00.000ZWoman reports retatrutide liver failure after injecting an unapproved vial https://peptide.zone/story/coming-off-glp-1-grocery-habits-revertPeptide Zoneen2026-10-31T04:07:00.000ZShoppers coming off GLP 1 drift back to old baskets within a year NielsenIQ says https://peptide.zone/story/dr-reddys-semaglutide-relaunch-novemberPeptide Zoneen2026-10-31T03:33:00.000ZIndian drugmaker plans November semaglutide relaunch after API impurity halt https://peptide.zone/story/samsung-biologics-polypeptide-offer-boardPeptide Zoneen2026-10-31T03:09:00.000ZSamsung Biologics PolyPeptide offer advances as shareholders elect new board